TNF Pharmaceuticals, Inc. (LON: 0A8D)
London
· Delayed Price · Currency is GBP · Price in USD 1.159
0.00 (0.00%)
At close: Jan 21, 2025
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of 2.55 million as of January 23, 2025. Its market cap has decreased by -69.69% in one year.
Market Cap
2.55M
Enterprise Value
-5.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.16
Market Cap Chart
Since April 20, 2021, TNF Pharmaceuticals's market cap has decreased from 142.21M to 2.55M, a decrease of -98.21%. That is a compound annual growth rate of -65.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 2.63M | 3.83% |
| Dec 31, 2024 | 2.53M | -75.52% |
| Dec 29, 2023 | 10.34M | -72.56% |
| Dec 30, 2022 | 37.67M | -77.64% |
| Dec 31, 2021 | 168.49M | 18.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| Shell | 167.06B |
| HSBC Holdings | 145.16B |
| Unilever | 114.25B |
| Rio Tinto Group | 85.64B |
| RELX PLC | 74.07B |
| BP p.l.c. | 67.25B |
| British American Tobacco p.l.c. | 65.03B |